TY - JOUR
T1 - Relationships between social withdrawal and facial emotion recognition in neuropsychiatric disorders
AU - de la Torre-Luque, Alejandro
AU - Viera-Campos, Alba
AU - Bilderbeck, Amy C.
AU - Carreras, Maria Teresa
AU - Vivancos, Jose
AU - Diaz-Caneja, Covadonga M.
AU - Aghajani, Moji
AU - Saris, Ilja M.J.
AU - Raslescu, Andreea
AU - Malik, Asad
AU - Clark, Jenna
AU - Penninx, Brenda W.J.H.
AU - van der Wee, Nic
AU - Rossum, Inge Winter van
AU - Sommer, Bernd
AU - Marston, Hugh
AU - Dawson, Gerard R.
AU - Kas, Martien J.
AU - Ayuso-Mateos, Jose Luis
AU - Arango, Celso
N1 - Funding Information: This study received funding from the European Union Seventh Framework Program under grant agreements and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No. 115916, Project PRISM, and grant agreement No. 777394, Project AIMS-2-TRIALS). Additionally, the study was supported by the Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III, co-financed by ERDF Funds from the European Commission, ?A way of making Europe?, CIBERSAM and Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, Familia Alonso Foundation and Alicia Koplowitz Foundation.Dr. Arango has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Minerva, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion and Takeda. Funding Information: This study received funding from the European Union Seventh Framework Program under grant agreements and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No. 115916 , Project PRISM, and grant agreement No. 777394 , Project AIMS-2-TRIALS). Additionally, the study was supported by the Spanish Ministry of Science and Innovation . Instituto de Salud Carlos III , co-financed by ERDF Funds from the European Commission , “A way of making Europe”, CIBERSAM and Madrid Regional Government ( B2017/BMD-3740 AGES-CM-2 ), European Union Structural Funds , Familia Alonso Foundation and Alicia Koplowitz Foundation . Publisher Copyright: © 2021
PY - 2022/3/8
Y1 - 2022/3/8
N2 - Background: Emotion recognition constitutes a pivotal process of social cognition. It involves decoding social cues (e.g., facial expressions) to maximise social adjustment. Current theoretical models posit the relationship between social withdrawal factors (social disengagement, lack of social interactions and loneliness) and emotion decoding. Objective: To investigate the role of social withdrawal in patients with schizophrenia (SZ) or probable Alzheimer's disease (AD), neuropsychiatric conditions associated with social dysfunction. Methods: A sample of 156 participants was recruited: schizophrenia patients (SZ; n = 53), Alzheimer's disease patients (AD; n = 46), and two age-matched control groups (SZc, n = 29; ADc, n = 28). All participants provided self-report measures of loneliness and social functioning, and completed a facial emotion detection task. Results: Neuropsychiatric patients (both groups) showed poorer performance in detecting both positive and negative emotions compared with their healthy counterparts (p < .01). Social withdrawal was associated with higher accuracy in negative emotion detection, across all groups. Additionally, neuropsychiatric patients with higher social withdrawal showed lower positive emotion misclassification. Conclusions: Our findings help to detail the similarities and differences in social function and facial emotion recognition in two disorders rarely studied in parallel, AD and SZ. Transdiagnostic patterns in these results suggest that social withdrawal is associated with heightened sensitivity to negative emotion expressions, potentially reflecting hypervigilance to social threat. Across the neuropsychiatric groups specifically, this hypervigilance associated with social withdrawal extended to positive emotion expressions, an emotional-cognitive bias that may impact social functioning in people with severe mental illness.
AB - Background: Emotion recognition constitutes a pivotal process of social cognition. It involves decoding social cues (e.g., facial expressions) to maximise social adjustment. Current theoretical models posit the relationship between social withdrawal factors (social disengagement, lack of social interactions and loneliness) and emotion decoding. Objective: To investigate the role of social withdrawal in patients with schizophrenia (SZ) or probable Alzheimer's disease (AD), neuropsychiatric conditions associated with social dysfunction. Methods: A sample of 156 participants was recruited: schizophrenia patients (SZ; n = 53), Alzheimer's disease patients (AD; n = 46), and two age-matched control groups (SZc, n = 29; ADc, n = 28). All participants provided self-report measures of loneliness and social functioning, and completed a facial emotion detection task. Results: Neuropsychiatric patients (both groups) showed poorer performance in detecting both positive and negative emotions compared with their healthy counterparts (p < .01). Social withdrawal was associated with higher accuracy in negative emotion detection, across all groups. Additionally, neuropsychiatric patients with higher social withdrawal showed lower positive emotion misclassification. Conclusions: Our findings help to detail the similarities and differences in social function and facial emotion recognition in two disorders rarely studied in parallel, AD and SZ. Transdiagnostic patterns in these results suggest that social withdrawal is associated with heightened sensitivity to negative emotion expressions, potentially reflecting hypervigilance to social threat. Across the neuropsychiatric groups specifically, this hypervigilance associated with social withdrawal extended to positive emotion expressions, an emotional-cognitive bias that may impact social functioning in people with severe mental illness.
KW - Alzheimer's disease
KW - Emotion recognition
KW - Neuropsychiatric disorder
KW - PRISM study
KW - Schizophrenia
KW - Social cognition
KW - Social functioning
UR - http://www.scopus.com/inward/record.url?scp=85118865844&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.pnpbp.2021.110463
DO - https://doi.org/10.1016/j.pnpbp.2021.110463
M3 - Article
C2 - 34718073
SN - 0278-5846
VL - 113
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
M1 - 110463
ER -